Alibaba to pay US $600m to settle allegations it allowed illegal drug and equipment sales
- The US alleges that AUS Merchant Services violated federal law
- Alibaba employees raised concerns that the company’s compliance controls were inadequate and failed to prevent the sale of illegal products
